Hoyoung Bae

Samsung Medical Center, Seoul National University

Papers

2

Total Citations

38

H-Index

2

About

Dr. Hoyoung Bae is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for urologic cancers, particularly upper tract urothelial carcinoma (UTUC) and renal tumors. His major contributions include landmark comparative studies on robotic radical nephroureterectomy (RNU), where he demonstrated that robotic approaches offer superior perioperative outcomes and oncological results compared to open and laparoscopic methods, with his 2022 study accumulating 21 citations and influencing surgical trend analyses. Dr. Bae has also been at the forefront of single-port robotic surgery, as evidenced by his 2024 propensity score-matched comparison showing that single-port retroperitoneal partial nephrectomy achieves comparable outcomes to multi-port techniques while potentially reducing morbidity—a study already cited 17 times. His work has helped establish robotic RNU as a standard of care for UTUC and has pushed the boundaries of what is possible with single-port platforms. With a growing citation impact and a focus on patient-centered outcomes, Dr. Bae is shaping the future of urologic oncology by making complex procedures safer, less invasive, and more accessible.

Research Focus

Key Achievements

2
H-Index
2
Papers
38
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study
21 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Samsung Medical Center, Seoul National University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago